# OnCo record ola-landgren (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/ola-landgren/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "ola-landgren" ;
  schema:name "C. Ola Landgren"@en ;
  schema:description "Showed that MGUS precedes essentially all myeloma and leads MRD-driven trials aiming for cure without transplant."@en ;
  schema:url <https://onco.cc/people/ola-landgren/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Landgren%20O%5BAuthor%5D%20myeloma%20MRD%20OR%20MGUS> ;
  onco:tag "myeloma", "mrd", "precursor" ;
  schema:jobTitle "Chief of Myeloma and Director of the Sylvester Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:targets <https://onco.cc/targets/cd38/> ;
  onco:institutions <https://onco.cc/institutions/sylvester-miami/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-jaiswal-chip-nejm-2014/> ;
  onco:journals <https://onco.cc/journals/jama-oncology/>, <https://onco.cc/journals/blood/> ;
  schema:affiliation <https://onco.cc/institutions/sylvester-miami/> .
